TRASYLOL NEWS RESOURCES
MORE EVIDENCE OF DANGER FROM HEART SURGERY DRUG
By Ed Edelson
HealthDay Reporter
Two new studies confirm an increased incidence of death and kidney damage among people given Trasylol (aprotinin), a drug used to reduce bleeding during coronary artery bypass surgeries. (story in pdf format - 37.4Kb)
Source: Washington Post
Published February 20, 2008
BAYER'S TRASYLOL BOOSTS DEATH, KIDNEY RISKS AFTER HEART SURGERY
By Michelle Fay Cortez
Bloomberg
Bayer AG's Trasylol, a drug whose sales were halted last year, raises the risk of death and kidney damage when used to control bleeding in heart surgery ... (story in pdf format -152Kb)
SOURCE:
Bloomberg
Published February 21, 2008
SAFETY CONCERNS PERSIST ABOUT APROTININ
Use of aprotinin during CABG was associated with significantly increased risk for death over 5 years of follow-up in real-world settings. [more on the concerns about Aprotinin...]
Source:Journal Watch
http://cardiology.jwatch.org
February 2007
Observational Studies of Drug Safety — Aprotinin and the Absence of Transparency
URL: http://healthpolicyandreform.nejm.org/?p=11545
From New England Journal of Medicine,
November 23, 2006
Judging the Safety of Aprotinin
URL: http://www.ncbi.nlm.nih.gov/pubmed/17131514
From New England Journal of Medicine
November 23, 2006
The Risk Associated with Aprotinin in Cardiac Surgery
Read about the risk associated with Aprotinin ...
Dennis T. Mangano, Ph.D., M.D., Iulia C. Tudor, Ph.D., Cynthia Dietzel, M.D., for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation
Abstract from article published in New England Journal of Medicine
January 26, 2006
Note: Free registration required to view Abstract. Fee required to view full text.
FDA Issues Half Hearted Public Health Advisory About Trasylol
Once again the Food and Drug Administration (FDA) has issued a Public Health Advisory in a manner that appears decidedly grudging and half hearted....
Read more on the half-hearted public health advisory of Trasylol...
Health Gazette
February 8, 2006
Bayer And Global Regulatory Authorities Evaluating Published Reports On Trasylol
Read about the authorities evaluating published reports on Trasylol...
Medilexicon Medical News
February 12, 2006
